Hypersensitivity. Acute venous or arterial thrombosis, fibrinolytic conditions following consumption coagulopathy except patients w/ predominant activation of fibrinolytic system w/ acute severe bleeding, severe renal impairment (risk of accumulation), history of convulsions, intrathecal & intraventricular inj, intracerebral application (risk of cerebral oedema & convulsions).